Canyon Capital Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,600,353
Closed -$59.4M 66
2022
Q1
$59.4M Sell
2,600,353
-401,900
-13% -$9.82M 2.2% 17
2021
Q4
$82.9M Buy
3,002,253
+46,253
+2% +$1.24M 2.82% 16
2021
Q3
$82.3M Buy
2,956,000
+505,000
+21% +$14.3M 2.9% 11
2021
Q2
$71.9M Buy
2,451,000
+286,000
+13% +$8.66M 2.67% 11
2021
Q1
$68.7M Sell
2,165,000
-1,618,872
-43% -$47.5M 2.73% 8
2020
Q4
$78.7M Buy
3,783,872
+778,716
+26% +$14.5M 3.4% 11
2020
Q3
$46.7M Buy
+3,005,156
New +$51.8M 1.73% 14

Other funds holding BHC

Canyon Capital Advisors's BHC Position: Q2 2022 in Review

Canyon Capital Advisors sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 2,600,353 shares — an estimated $59.4M sold.

Canyon Capital Advisors first reported a position in BHC in Q3 2020 and held it in 7 quarters. The position peaked at $82.9M in Q4 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Canyon Capital Advisors reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Canyon Capital Advisors sold 2,600,353 Bausch Health shares in Q2 2022, an estimated $59.4M.
  • Canyon Capital Advisors first reported a position in Bausch Health in Q3 2020 and held it in 7 quarters.
  • Canyon Capital Advisors's Bausch Health position peaked at $82.9M in Q4 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Canyon Capital Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.